Tokyo Tape
Sign in
← Nippon Kayaku

Quarterly report · Q2

4272.TEDINET S100PHL2
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥102.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥184.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥88.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥13.6bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥10.9bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥16.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥23.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥11.8bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥16.4bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥13.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥11.3bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥9.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥329.5bnat 2022-09-30Cons.Assets
Total assets¥315.5bnat 2022-03-31Cons.Assets
Total assets¥302.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥70.3bnat 2022-09-30Cons.Liabilities
Total liabilities¥69.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥259.2bnat 2022-09-30Cons.Net assets
Net assets / equity¥246.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥233.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥41.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥38.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥52.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥53.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥50.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥47.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥6.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥11.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥67.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.632022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.272021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.352021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥67.022022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥101.652021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥54.262021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio78.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio77.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 52
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥4.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥899m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥137m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥137m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥3.7bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥46.1bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥46.0bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥82m
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥7.8bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue external2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E00836-000Medicinereportable segmentsegment profit2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue2022-04-01 → 2022-09-30¥26.7bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue external2022-04-01 → 2022-09-30¥26.7bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.0bn
—segment totalrevenue2022-04-01 → 2022-09-30¥98.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥98.1bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥82m
—segment totalsegment profit2022-04-01 → 2022-09-30¥16.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥102.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥102.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥137m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥17.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥4.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥4.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥51m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥919m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥123m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥123m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥3.4bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥37.7bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥37.6bn
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥71m
jpcrp040300-q2r_E00836-000Functional Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥6.1bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue external2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00836-000Medicinereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥0
jpcrp040300-q2r_E00836-000Medicinereportable segmentsegment profit2021-04-01 → 2021-09-30¥4.1bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue2021-04-01 → 2021-09-30¥21.6bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentrevenue external2021-04-01 → 2021-09-30¥21.6bn
jpcrp040300-q2r_E00836-000Safety Systemsreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.2bn
—segment totalrevenue2021-04-01 → 2021-09-30¥84.8bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥84.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥71m
—segment totalsegment profit2021-04-01 → 2021-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥89.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥88.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥123m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥14.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 583
ItemContextValueUnit
Short term loans payableCurrentQuarterInstant2070000000JPY
Current portion of bondsPrior1YearInstant4000000000JPY
Current portion of bondsCurrentQuarterInstant4000000000JPY
Accounts payable otherPrior1YearInstant9617000000JPY
Accounts payable otherCurrentQuarterInstant9524000000JPY
Income taxes payablePrior1YearInstant2997000000JPY
Income taxes payableCurrentQuarterInstant3442000000JPY
Other clPrior1YearInstant7956000000JPY
Other clCurrentQuarterInstant7087000000JPY
Current liabilitiesPrior1YearInstant45760000000JPY
Current liabilitiesCurrentQuarterInstant47941000000JPY
Bonds payablePrior1YearInstant8000000000JPY
Bonds payableCurrentQuarterInstant8000000000JPY
Long term loans payablePrior1YearInstant1474000000JPY
Long term loans payableCurrentQuarterInstant824000000JPY
Net defined benefit liabilityPrior1YearInstant380000000JPY
Net defined benefit liabilityCurrentQuarterInstant413000000JPY
Other nclPrior1YearInstant13419000000JPY
Other nclCurrentQuarterInstant13084000000JPY
Noncurrent liabilitiesPrior1YearInstant23273000000JPY
Noncurrent liabilitiesCurrentQuarterInstant22322000000JPY
LiabilitiesPrior1YearInstant69034000000JPY
LiabilitiesCurrentQuarterInstant70264000000JPY
Capital stockPrior1YearInstant14932000000JPY
Capital stockCurrentQuarterInstant14932000000JPY
Capital surplusPrior1YearInstant15759000000JPY
Capital surplusCurrentQuarterInstant15785000000JPY
Retained earningsPrior1YearInstant195566000000JPY
Retained earningsCurrentQuarterInstant202639000000JPY
Treasury stockPrior1YearInstant-2624000000JPY
Treasury stockCurrentQuarterInstant-2523000000JPY
Shareholders equityPrior1YearInstant223633000000JPY
Shareholders equityCurrentQuarterInstant230835000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant9818000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant8386000000JPY
Foreign currency translation adjustmentPrior1YearInstant10630000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant17761000000JPY
Remeasurements of defined benefit plansPrior1YearInstant1396000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant1224000000JPY
Valuation and translation adjustmentsPrior1YearInstant21846000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant27372000000JPY
Non controlling interestsPrior1YearInstant945000000JPY
Non controlling interestsCurrentQuarterInstant1031000000JPY
Net assetsPrior1YearInstant246425000000JPY
Net assetsCurrentQuarterInstant259239000000JPY
Liabilities and net assetsPrior1YearInstant315459000000JPY
Liabilities and net assetsCurrentQuarterInstant329503000000JPY
Net salesPrior1YTDDuration88840000000JPY
Net salesCurrentYTDDuration102728000000JPY
Cost of salesPrior1YTDDuration57622000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass